Lyell Immunopharma, Inc. · NASDAQ:LYEL
Innovative Cellular Therapeutics Holdings Limited reported a 12.30% stake in Lyell Immunopharma, Inc. (Schedule 13G/A)
Event May 18, 2026 · Filed Jun 18, 2026
Innovative Cellular Therapeutics Holdings Limited reported a 12.30% stake in Lyell Immunopharma, Inc., 3,000,000 shares, as a passive investor on May 18, 2026. Filed Jun 18, 2026 (Schedule 13G/A).
- Stake
- 12.30%
- Shares
- 3,000,000
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Innovative Cellular Therapeutics Holdings Limited | 12.30% | 3,000,000 |
Source
Related
- Lyell Immunopharma, Inc.
- Innovative Cellular Therapeutics Holdings Ltd
- Lyell Immunopharma, Inc. shareholders
- Schedule 13G · Innovative Cellular Therapeutics Holdings Ltd · Nov 13, 2025
- Form 4 · Aguirre Jarrad Mattieu · Oct 13, 2026
- Form 4 · Shook David · Sep 10, 2026
- Form 4 · Seely Lynn · Aug 25, 2026
- Form 4 · Hill Stephen J. · Aug 25, 2026
- Form 4 · Lee Gary K. · Aug 25, 2026